Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JCOG2205 S-FACT early breast cancer platform trial
jRCT2031240159Recruiting
- Start
- Jul 2024
- Countries
- 1
01
Overview
Randomised, open-label trial in breast cancer (2 arms). Primary endpoints: Pathological complete response and Proportion of ctDNA clearance. Started Jul 2024; status: recruiting.
02
Conditions
breast cancer
Beyond the preview
Go deeper on jRCT2031240159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240159.